Class II
Ongoing
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
This recall is currently active, issued January 28, 2026. It was issued by Graviti Pharmaceuticals Private Limited.
- Recall Initiated
- January 10, 2026
- Posted
- January 28, 2026
- Recall Number
- D-0293-2026
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 4212 bottles
- Firm Location
- Hyderabad, India
- Official Source
- View on FDA website ↗
Reason for Recall
Presence of Foreign Substance
Distribution
U.S. Nationwide
Lot / Code Info
Lot# FUB125042G; Exp. 05/13/2027
More recalls by Graviti Pharmaceuticals Private Limited
Other recent Class II Drug recalls
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, L...
Wizcure Pharmaa Private Limited
· Mar 4, 2026
Amantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: Av...
Avkare
· Mar 4, 2026
Agebox iKids-Growth (Day Formula) capsules, 60-count bottles, Manufactured Exclusively For: AGEBOX I...
Agebox
· Mar 4, 2026
Adbry, (tralokinumab-ldrm) injection, 300 mg/2mL, Packaged as a) 1 x Single dose Autoinjector, SAMPL...
Leo Pharma Inc
· Mar 4, 2026
Pro Numb Tattoo Numbing Spray, For Sensitive Skin, 4% Lidocaine, [1FL OZ/28.4 ML or 4 oz/120 mL] per...
Pro Numb Tattoo Numbing Spray Llc
· Feb 18, 2026